INTERNATIONAL PATENT: PHIO PHARMACEUTICALS CORP. FILES APPLICATION FOR "INTRATUMORAL TARGETING OF PD-1"

GENEVA, May 19 -- PHIO PHARMACEUTICALS CORP. (257 Simarano DriveSuite 101Marlborough, MA 01752) filed a patent application (PCT/US2023/085041) for "INTRATUMORAL TARGETING OF PD-1" on Dec 20, 2023. With publication no. WO/2025/101204, the details related to the patent application was published on May 15, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): BITTERMAN, Robert (C/o Phio Pharmaceuticals Inc.257 Simarano DriveSuite 101Marlborough, MA 01752)

Abstract: Aspects of the disclosure relate to methods for treating disorders such as cutaneous squamous cell carcinoma (cSCC) in a subject havin...